{"prompt": "['Novartis', 'Confidential', 'Page 74', 'Amended Protocol Version v02/Clean', 'Protocol No. CQVM149B2306', 'Bateman ED, Boushey HA, Bousquet J et al (2004) Can Guideline-defined Asthma control Be', 'Achieved? The Gaining optimal Asthma Control Study. Am J Respir Crit Care Med;170:836-', '844.', 'Bateman ED, Kormmann O, Schmidt P et al (2011) Tiotropium is non inferior to salmeterol in', 'maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin', 'Immunol 2011; 128:315-22.', 'Beakes DE (1997) The use of anticholinergics in asthma. J Asthma 34 (5): 357-368).', 'Masoli M, Fabian D, Holt S et al (2004). The global burden of asthma: executive summary of', 'the GINA Dissemination Committee report, Global Initiative for Asthma (GINA) Program.', 'Available from GINA website.', 'Beasley R, Lanier B, Varkonyi I et al (2012). Safety of once-daily QMF149 in patients with', 'persistent asthma. Eur Respir J; 40 (Suppl 56).', 'Beasley R, Lanier B, Mark Z et al (2012a). Long-term efficacy of QMF149 in persistent', 'asthma. Eur Respir J; 40 (Suppl 56).', 'Beasley R., Donohue, James F, Mehta R et al (2015). Effect of once-daily indacaterol', 'maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-', 'blind randomised controlled trial; BMJ Open 5:e006131. doi: 10.1136/bmjopen-2014-006131', 'Befekadu E, Onofrei C, Colice GL (2014) . Tiotropium in asthma, a systemic review. JAA;7:', '11-21.', \"Brannath et al. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily\", 'correlated test statistics. Biometrical Journal 2009; 51(6): 885-898', 'Bretz F, Maurer W, Brannath W et al (2009). A graphical approach to sequentially rejective', 'multiple test procedures. Statistics in Medicine; 28: 586-604.', 'Bretz F, Posch M, Glimm E, et al (2011). Graphical approaches for multiple comparison', 'procedures using weighted Bonferroni, Simes, or parametric tests. Biometrical Journal; 53:', '894-913.', 'Chapman KR, Beeh KM, Beier J, et al. (2014) A blinded evaluation of the efficacy and safety', 'of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in', 'patients with COPD: the GLOW5 study. BMC Pulm Med. 2014;14:4.', 'ANON, European Medicines Agency (2013). Note for guidance on clinical investigation of', 'medicinal products for treatment of asthma. CHMP/EWP/2922/01-rev.1. 27 June 2013.', 'Fardon T, Haggart K, Lee DKC et al (2007) A proof of concept study to evaluate stepping', 'down the dose of fluticasone in combination with salmeterol and tiotropium in severe', 'persistent asthma. Respiratory Medicine; 101: 1218-1228.', 'Global Initiative for Asthma (GINA) 2017 Global Strategy for Asthma Management and', 'Prevention ) http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-', 'and-prevention/', 'Guyer AC, Long AA (2013) Long-acting anticholinergics in the treatment of asthma. Allergy', 'Clin Immunol; 13:392-398']['Novartis', 'Confidential', 'Page 75', 'Amended Protocol Version v02/Clean', 'Protocol No. CQVM149B2306', 'Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE (1993) Measuring quality of life in asthma.', 'AmRev Respir Dis.; 147(4):832-8', 'Juniper EF, Guyatt GH, Ferrie PJ et al (1994) Determining a minimal important change in a', 'disease-specific quality of life questionnaire. J Clin Epidemiol; 47: 81-87.', \"Juniper EF, O'Byrne PM, Guyatt GH et al (1999) Development and validation of the\", 'questionnaire to measure asthma control. Eur Resp J; 14: 902-907.', 'Juniper EF, Svensson K, Mork AC et al. Measurement properties and interpretation of three', 'shortened versions of the asthma control questionnaire. Respir Med 2005; 99:553-8.', 'Juniper EF, Bousquet J, Abetz L et al (2006) Identifying \"well-controlled\\' and \"not well-', \"controlled' asthma usingthe Asthma Control Questionnaire. Respir Med; 100: 616-21.\", 'Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum', 'likelihood. Biometrics 1997; 53(3):983-97.', 'Kerstjens HAM, Disse B, Schroder-Babo, W et al (2011) Tiotropium improves lung', 'function in patients with severe uncontrolled asthma: A randomized controlled trial. J', 'Allergy Clin Immunol; 128:308-314.', 'Kerstjens HAM, Engle M, Dahl R, et al (2012). Tiotropium in Asthma Poorly Controlled with', 'Standard Combination Therapy. N Engl J Med; 367: 1198-1207', 'Kerstjens HAM, Casale T, Blecker E, et al (2015) Tiotropium or salmeterol as add-on therapy', 'to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate,', 'double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. Lancet', 'Respir Med.3(5):367-76', 'Masoli M et al (2004). The Global Burden of Asthma Report, Global Initiative for Asthma', '(GINA). ttp://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-', 'prevention/', 'Peters SP, Kunselman J., SicitovicN et al (2010) Tiotropium bromide step-up therapy for', 'adults with uncontrolled asthma. N Engl J Med; 363(18): 1715-1726.', 'Quanjer PH., Tammeling, GJ, Coites,JE et al. (1993), Lung volumes and forced ventilatory', 'flows. Report Working Party Standardization of Lung Function Tests, European Community', 'for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J; 6', 'suppl. 16: 5-40.', 'Rohmeyer K, Klinglmueller F, and Bornkamp B (2012). Package \"gMCP\\' graph based', 'multiple comparison procedures: http://cran.r-project.org/web/packages/gMCP/gMCP.pdf', 'Testi 2014, White Paper, Long Acting Muscarinic Agent (LAMA). A new Frontier for COPD', 'and Asthma Treatment. Available on www.cromsource.com', 'Vaidya S, Khindri S, Robertson J, et al (2012) Pharmacokinetics (PK) of single doses of', 'mometasone furoate (MF) delivered via the Breezhaler\u00ae (BH) and Twisthaler devices in', 'healthy subjects. Eur Respir J; 40 (Suppl 56): P382.']\n\n###\n\n", "completion": "END"}